Age (y)† | 74 [29–94] | 69 [35–93] | 0.56 |
Follow up (months)† | 50 [26–82] | 43 [2.5–86] | 0.02 |
Sex (female/male) | 19 (79%)/5 (212%) | 59 (50%)/59 (50%) | 0.0123 |
Perineural invasion, lymphovascular invasion, or presence of vascular neoplastic emboli (Y/N) | 4 (17%)/20 (83%) | 45 (38%)/73 (62%) | 0.058 |
Perineural invasion (Y/N) | 2 (8%)/22 (92%) | 24 (20%)/94 (80%) | 0.24 |
Lymphovascular invasion (Y/N) | 1 (4%)/23 (96%) | 20 (17%)/98 (83%) | 0.20 |
Presence of vascular neoplastic emboli (Y/N) | 1 (4%)/23 (96%) | 16 (14%)/102 (86%) | 0.30 |
Right sided tumour (Y/N) | 19 (79%)/5 (21%) | 59 (50%)/59 (50%) | 0.012 |
Recurrence (Y/N) | 0 (0%)/24 (100%) | 15 (13%)/103 (87%) | 0.07 |